for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Inovio's HIV vaccine produces nearly 100 pct immune response rates in clinical study

May 24 (Reuters) - Inovio Pharmaceuticals Inc

* Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

* Inovio Pharmaceuticals Inc - amongst evaluated participants receiving PENNVAX-GP and IL-12 via im vaccination, 27 of 27 demonstrated a cellular response Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up